A 12-WEEK TREATMENT WITH BUDESONIDE ORODISPERSIBLE TABLETS IN THE EOS-1 TRIAL FOR INCOMPLETE RESPONDERS SIGNIFICANTLY IMPROVES BOTH INFLAMMATORY AND FIBROSTENOTIC ENDOSCOPIC FEATURES IN ADULT PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS

Stephan Miehlke  1     Alfredo J. Lucendo  2     Christoph Schlag  3     Ulrike von Arnim  4     Javier Molina Infante  5     Christoph Schmöcker  6     Albert Jan Bredenoord  7     Constanza Ciriza De Los Ríos     Stefan Brückner     Ahmed Madisch     Stefan Schubert     Jamal Hayat     Stephen E. Attwood     Jan Tack     Ralph Mueller     Roland Greinwald     Alex Straumann     Alain M. Scho    
1 Center for Digestive Diseases, Internal Medicine Center Eppendorf,Hamburg,Germany
2 Hospital General de Tomelloso,Tomelloso,Spain
3 Klinikum rechts der Isar - TU München,München,Germany
4 University Hospital Magdeburg,Madgeburg,Germany
5 Hospital San Pedro de Alcantara,Caceres,Spain
6 Sana Klinikum Lichtenberg,Berlin,Germany
7 Academisch M

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing